Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 70/100

ResMed Announces Participation in the UBS Global Healthcare Conference

Key Takeaway: ResMed announced that its CEO Mick Farrell and CMO Dr. Carlos Nunez will participate in a fireside chat at the UBS Global Healthcare Conference on November 12, 2024. This engagement provides an opportunity for ResMed to showcase its innovative healthcare solutions. The conference will be held at the Terranea Resort Hotel in California and will include a live, audio-only webcast. ResMed continues to emphasize its mission to improve the quality of life for individuals with chronic diseases through its digital health technologies and cloud-connected devices.

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference indicates strong engagement with industry leaders.
  • Showcases their commitment to innovation in health technology.
  • Opportunity for ResMed to highlight their advancements in treating chronic diseases.

Full Press Release Details

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at approximately 3:30 p.m. (Pacific Standard Time) at the Terranea Resort Hotel in Rancho Palos Verdes, CA.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors For media
+1 858.836.5000 +1 619.510.1281
investorrelations@resmed.com news@resmed.com

Frequently Asked Questions

When is ResMed's fireside chat at the UBS Global Healthcare Conference?

The fireside chat is on November 12, 2024, at approximately 3:30 p.m. PST.

Who will represent ResMed at the UBS conference?

Mick Farrell and Dr. Carlos Nunez will represent ResMed.

How can I access the live webcast of the event?

Visit https://investor.resmed.com for access to the live webcast.

Will there be a replay of the webcast available?

Yes, the replay will be accessible 24 hours after the event for 30 days.

What does ResMed specialize in?

ResMed specializes in digital health technologies for chronic disease management.

Last updated: Nov 5, 2024